6491 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 11
00:02 UTC
|
MLCO
Melco Resorts & Entertainment
|
◎ Target | George Choi ★★★☆☆ #1738 | Buy | $10.50→ $9.40-10.5% |
|
Jul 11
00:02 UTC
|
MKTX
MarketAxess
|
◎ Target | Michael Cyprys ★★☆☆☆ #2215 | Equal Weight | $195.00→ $129.00-33.8% |
|
Jul 11
00:02 UTC
|
MIR
Mirion Technologies
|
◎ Target | Joe Ritchie ★★☆☆☆ #2338 | Buy | $28.00→ $25.00-10.7% |
|
Jul 11
00:02 UTC
|
MIAX
Miami International
|
◎ Target | Michael Cyprys ★★☆☆☆ #2215 | Overweight | $50.00→ $53.00+6.0% |
|
Jul 11
00:02 UTC
|
MGY
Magnolia Oil & Gas
|
◎ Target | Peyton Dorne ★★★☆☆ #1614 | Buy | $38.00→ $34.00-10.5% |
|
Jul 11
00:02 UTC
|
META
Meta Platforms
|
◎ Target | Andrew Boone ★☆☆☆☆ #2492 | Market Outperform | $825.00→ $800.00-3.0% |
|
Jul 11
00:02 UTC
|
MET
MetLife
|
◎ Target | Suneet Kamath ★★★★☆ #429 | Buy | $97.00→ $103.00+6.2% |
|
Jul 11
00:02 UTC
|
MDT
Medtronic
|
◎ Target | Joshua Jennings not yet tracked | Buy | $119.00→ $100.00-16.0% |
|
Jul 11
00:02 UTC
|
MDB
MongoDB
|
◎ Target | Mike Cikos ★★★★★ #74 | Buy | $400.00→ $430.00+7.5% |
|
Jul 11
00:02 UTC
|
MCO
Moody's
|
◎ Target | Manav Patnaik ★★★★★ #157 | Overweight | $550.00→ $575.00+4.5% |
|
Jul 11
00:02 UTC
|
MC
Moelis & Company
|
◎ Target | Aidan Hall not yet tracked | Market Perform | $69.00→ $66.00-4.3% |
|
Jul 11
00:02 UTC
|
MAT
Mattel
|
◎ Target | James Hardiman ★★★☆☆ #1522 | Neutral | $16.00→ $15.00-6.2% |
|
Jul 11
00:02 UTC
|
MAIR
Madison Air Solutions
|
◎ Target | Zachary Schechtman not yet tracked | Overweight | $47.00→ $46.00-2.1% |
|
Jul 11
00:02 UTC
|
LVS
Las Vegas Sands
|
◎ Target | George Choi ★★★☆☆ #1738 | Buy | $78.50→ $73.00-7.0% |
|
Jul 11
00:02 UTC
|
LRCX
Lam Research
|
◎ Target | Charles Shi ★★★☆☆ #1139 | Buy | $300.00→ $390.00+30.0% |
|
Jul 11
00:02 UTC
|
LRCX
Lam Research
|
◎ Target | Brian Chin ★★★☆☆ #1019 | Buy | $325.00→ $425.00+30.8% |
|
Jul 11
00:02 UTC
|
LPLA
LPL Financial
|
◎ Target | Michael Cyprys ★★☆☆☆ #2215 | Overweight | $374.00→ $387.00+3.5% |
|
Jul 11
00:02 UTC
|
LNC
Lincoln National
|
◎ Target | Suneet Kamath ★★★★☆ #429 | Buy | $56.00→ $57.00+1.8% |
|
Jul 11
00:02 UTC
|
LLY
Eli Lilly and Company
|
◎ Target | Jason Gerberry ★★★☆☆ #1543 | Buy | $1,251.00→ $1,334.00+6.6% |
|
Jul 11
00:02 UTC
|
LIND
Lindblad Expeditions
|
◎ Target | Steven Wieczynski ★★★☆☆ #1457 | Buy | $27.00→ $32.00+18.5% |
|
Jul 11
00:02 UTC
|
LGN
LGN
|
◎ Target | Joseph Osha ★☆☆☆☆ #2540 | Buy | $106.00→ $115.00+8.5% |
|
Jul 11
00:02 UTC
|
LEVI
Levi Strauss & Co.
|
◎ Target | Adrienne Yih ★★★☆☆ #1686 | Overweight | $26.00→ $27.00+3.8% |
|
Jul 11
00:02 UTC
|
LEA
Lear
|
◎ Target | Rajat Gupta not yet tracked | Overweight | $153.00→ $159.00+3.9% |
|
Jul 11
00:02 UTC
|
LDOS
Leidos
|
◎ Target | Tobey Sommer ★★★☆☆ #927 | Buy | $195.00→ $160.00-17.9% |
|
Jul 11
00:02 UTC
|
LAZ
Lazard
|
◎ Target | Alex Bond ★★☆☆☆ #1840 | Market Perform | $49.00→ $44.00-10.2% |
|
Jul 11
00:02 UTC
|
LAD
Lithia Motors
|
◎ Target | Robert Saltzman not yet tracked | Buy | $348.00→ $370.00+6.3% |
|
Jul 11
00:02 UTC
|
KVYO
Klaviyo
|
◎ Target | Parker Lane not yet tracked | Buy | $28.00→ $24.00-14.3% |
|
Jul 11
00:02 UTC
|
KO
CocaCola
|
◎ Target | Andrea Teixeira not yet tracked | Overweight | $85.00→ $90.00+5.9% |
|
Jul 11
00:02 UTC
|
KO
CocaCola
|
◎ Target | Peter Galbo ★★★☆☆ #1527 | Buy | $90.00→ $95.00+5.6% |
|
Jul 11
00:02 UTC
|
KNX
Knight-Swift Transportation
|
◎ Target | Brian Ossenbeck ★★★☆☆ #803 | Neutral | $70.00→ $77.00+10.0% |
|
Jul 11
00:02 UTC
|
KLAC
KLA
|
◎ Target | Brian Chin ★★★☆☆ #1019 | Buy | $191.00→ $270.00+41.4% |
|
Jul 11
00:02 UTC
|
KLAC
KLA
|
◎ Target | Charles Shi ★★★☆☆ #1139 | Buy | $200.00→ $270.00+35.0% |
|
Jul 11
00:02 UTC
|
KKR
KKR & Co. Inc.
|
◎ Target | Benjamin Budish ★★★☆☆ #1379 | Overweight | $122.00→ $124.00+1.6% |
|
Jul 11
00:02 UTC
|
JNJ
Johnson & Johnson
|
◎ Target | Tim Anderson not yet tracked | Neutral | $254.00→ $263.00+3.5% |
|
Jul 11
00:02 UTC
|
JELD
JELD-WEN
|
◎ Target | Susan Maklari ★★★☆☆ #1684 | Neutral | $1.75→ $1.50-14.3% |
|
Jul 11
00:02 UTC
|
JBHT
J.B. Hunt Transport Services
|
◎ Target | Brian Ossenbeck ★★★☆☆ #803 | Overweight | $227.00→ $280.00+23.3% |
|
Jul 11
00:02 UTC
|
IT
Gartner
|
◎ Target | Toni Kaplan ★★★☆☆ #1718 | Equal Weight | $183.00→ $173.00-5.5% |
|
Jul 11
00:02 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Eric Joseph ★★★☆☆ #1108 | Buy | $115.00→ $100.00-13.0% |
|
Jul 11
00:02 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Eliana Merle ★★★★☆ #464 | Overweight | $115.00→ $90.00-21.7% |
|
Jul 11
00:02 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Gary Nachman ★☆☆☆☆ #2374 | Buy | $110.00→ $95.00-13.6% |
|
Jul 11
00:02 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $130.00→ $125.00-3.8% |
|
Jul 11
00:02 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Michael Ulz ★★☆☆☆ #2324 | Overweight | $130.00→ $110.00-15.4% |
|
Jul 11
00:02 UTC
|
INTC
Intel
|
◎ Target | Ruben Roy ★★★☆☆ #787 | Hold | $75.00→ $120.00+60.0% |
|
Jul 11
00:02 UTC
|
INFY
Infosys
|
◎ Target | James Friedman ★★☆☆☆ #1944 | Neutral | $14.00→ $12.00-14.3% |
|
Jul 11
00:02 UTC
|
IGM
IGM Financial
|
◎ Target | firm only | C$79.00→ C$85.00+7.6% | |
|
Jul 11
00:02 UTC
|
IFC
Intact Financial
|
◎ Target | firm only | C$288.00→ C$314.00+9.0% | |
|
Jul 11
00:02 UTC
|
ICHR
Ichor
|
◎ Target | Brian Chin ★★★☆☆ #1019 | Buy | $76.00→ $115.00+51.3% |
|
Jul 11
00:02 UTC
|
ICE
Intercontinental Exchange
|
◎ Target | Michael Cyprys ★★☆☆☆ #2215 | Equal Weight | $187.00→ $163.00-12.8% |
|
Jul 11
00:02 UTC
|
HSX
Hiscox
|
◎ Target | firm only | Overweight | GBX 1,800→ GBX 2,050+13.9% |
|
Jul 11
00:02 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Michael Cyprys ★★☆☆☆ #2215 | Equal Weight | $95.00→ $124.00+30.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.